SAN FRANCISCO, March 9, 2023 /PRNewswire/ — Ausper Biopharma Co., Ltd. and AusperBio Therapeutic, Inc. (Together AusperBio) today announced the completion of the first cohort dosing in a Phase 1 clinical trial evaluating AHB–137 in adult healthy volunteers and chronic hepatitis B (CHB)…
Month: March 2023
LONDON, March 9, 2023 /PRNewswire/ — Elliott Advisors (UK) Limited (“Elliott”), which advises funds that together hold a significant investment in Dai Nippon Printing (“DNP” or “the Company”), commends DNP’s commitment to execute the largest share buyback in the Company’s history by…
DUBLIN, March 9, 2023 /PRNewswire/ — The “Europe Alternative Protein Market (2023 Edition) – Analysis By Product Type, Application, Sales Channel, By Region, By Country: Market Size, Insights, Competition, Covid-19 Impact and Forecast (2023-2028)” report has been added to…
NEW YORK, March 9, 2023 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of National Realty Investment Advisors LLC membership units (NRIA) of the important March 13, 2023 lead plaintiff deadline in the securities class action. The case is against…
